Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Immunol. 2012 Jan 30;188(5):2146–2155. doi: 10.4049/jimmunol.1004120

Figure 3. Targeted cells in draining lymph nodes are mature, skin-derived DCs.

Figure 3

1μg IgG2a control or anti-DEC-205 mAb were injected intradermally into the ears of C57BL/6 mice. Two days later, targeting antibodies were detected in permeabilised lymph nodes cells by anti-rat IgG / APC. (A) CD11b expression and levels of targeting antibody were evaluated in lymph node cells. (B) CD11b+ targeting antibody+ cells were gated and expression of MHC class II, CD11c, Langerin and CD8α was evaluated. Percentages of Langerinneg and Langerin+ cells among gated cells are shown. (C) Comparison of the amount of anti-DEC-205 mAb detected in Langerinneg and Langerin+ subsets of CD11b+ targeting antibody+ lymph node cells. MFI: mean fluorescence intensity. Results are representative of at least three independent experiments.

HHS Vulnerability Disclosure